-
In women surviving to older ages, diet quality at midlife appears to be strongly associated with a greater likelihood of not having mental and physical limitations.
-
Colicky children given probioitics had more fussing, as per sub-group analyses than children given placebo. In addition, probiotics did not affect the amount of time spent crying.
-
Breast cancer survivors participating in a 12-week yoga program reported decreased fatigue, increased vitality, and improved sleep on multiple scoring systems, but no impact on depressive symptoms. Increased time spent doing yoga led to greater improvements in inflammation, mood, and fatigue.
-
Investigators combined multiple meta-analyses to assess the relative effectiveness of drug therapy and exercise in reducing mortality from specific causes. Exercise produced a comparable or better effect for all causes.
-
In Part 1, the authors reviewed the clinical aspects of insulin dosing and titration for primary care physicians. In this section, the authors review new and emerging insulin products, the practical aspects of writing insulin prescriptions, delivery of insulin, and advanced insulin delivery systems (via pump and patch).
-
Bayer HealthCare Pharmaceuticals has received Food and Drug Administration approval for a new inserter for its Mirena intrauterine contraceptive.
-
New chlamydia prevalence estimates confirm that young women particularly young African American women continue to bear a disproportionate burden of disease in the United States.
-
Results from the 2013 National Youth Risk Behavior Survey indicate that among high school students who are sexually active, condom use has declined from 63% in 2003 to 59% in 2013. This decline follows a period of increased condom use throughout the 1990s and early 2000s.
-
Its estimated that 859 out of 100,000 women of reproductive age receive a cancer diagnosis each year in the United States. Up to 80% of all women diagnosed with cancer prior to age 50 survive at least five years.
-
A new campaign, Start Talking. Stop HIV, developed by the Centers for Disease Control and Prevention encourages gay and bisexual men to talk openly with their sexual partners about HIV risk and prevention strategies.
